Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Change in Cash (2022 - 2025)

Gossamer Bio's Change in Cash history spans 4 years, with the latest figure at $28.8 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 63.54% year-over-year to $28.8 million; the TTM value through Dec 2025 reached -$8.3 million, down 159.74%, while the annual FY2025 figure was -$8.3 million, 159.74% down from the prior year.
  • Change in Cash reached $28.8 million in Q4 2025 per GOSS's latest filing, up from -$17.4 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $59.2 million in Q3 2022 to a low of -$58.4 million in Q3 2024.
  • Average Change in Cash over 4 years is -$9.1 million, with a median of -$17.2 million recorded in 2025.
  • Peak YoY movement for Change in Cash: skyrocketed 270.03% in 2024, then tumbled 352.49% in 2025.
  • A 4-year view of Change in Cash shows it stood at -$41.5 million in 2022, then dropped by 21.68% to -$50.5 million in 2023, then surged by 134.87% to $17.6 million in 2024, then soared by 63.54% to $28.8 million in 2025.
  • Per Business Quant, the three most recent readings for GOSS's Change in Cash are $28.8 million (Q4 2025), -$17.4 million (Q3 2025), and -$2.7 million (Q2 2025).